Sopharma stock heads toward an October 30 shareholder vote
Published on 10/08/2026 at 04:25 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Sopharma stock (ISIN BG11SOSOBT18) had a market capitalization of PLN 5.7 billion as of October 7, 2026. The next defined corporate checkpoint is an extraordinary shareholder meeting scheduled for October 30, 2026, with an alternative date of November 20 if a quorum is not reached, according to PAP MediaRoom.
October 30 vote sets the next checkpoint
The meeting agenda includes approval of Sopharma's six-month financial report for the first half of 2026. It also includes a decision on distributing profit and paying an interim dividend based on that report, according to PAP MediaRoom on September 25, 2026.
For investors, the vote links capital allocation with the latest interim accounts. The same meeting materials also include the selection of a registered auditor for the 2026 consolidated sustainability report, if applicable.
June revenue fell from the prior year
Sopharma reported revenue of EUR 374.54 million for the period ended June 2026, compared with EUR 637.01 million for June 2025, a decline of 41.2 percent. The figures are listed in the latest earnings table from Investing.com.
The same table shows reported earnings per share of EUR 0.03 for June 2026. That compares with EUR 0.06 for June 2025, giving shareholders a second year-over-year measure for the upcoming dividend discussion, according to Investing.com.
Pharmaceutical group keeps a broad footprint
Sopharma AD produces and trades generic medicines, medical substances and finished drug forms, while also conducting research and development in medical products. Its portfolio includes analgesic, cardiovascular and respiratory treatments, according to MarketScreener.
Shareholder vote comes into view
The October 30 meeting puts the first-half report, dividend allocation and audit arrangements on the same corporate calendar. Sopharma stock's market capitalization was PLN 5.7 billion on October 7, 2026, giving the scheduled vote a clear market-value context.
Key facts on Sopharma stock
- Company: Sopharma AD
- ISIN: BG11SOSOBT18
- Ticker: SFA
- Trading venue: BSE Sofia
- Market capitalization: PLN 5.7 billion (as of October 7, 2026)
- Sector / Industry: Healthcare / Drug Retailers
Upcoming dates for Sopharma stock
- October 30, 2026: Extraordinary general meeting of shareholders
- November 20, 2026: Alternative extraordinary general meeting date if a quorum is not reached
